Molecular targets in the inhibition of angiogenesis (Q35186667)

7 August 2017

1 reference

title

Molecular targets in the inhibition of angiogenesis (English)

1 reference

7 August 2017

Arkadiusz Z Dudek

1

1 reference

7 August 2017

Wojciech Z Pawlak

series ordinal

2

1 reference

7 August 2017

Mark N Kirstein

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Therapeutic Targets

7 August 2017

published in

1 reference

7 August 2017

volume

7

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

527-541

1 reference

Hemangioblast development and regulation

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Transforming growth factor beta-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The 16K Fragment of Prolactin Specifically Inhibits Basal or Fibroblast Growth Factor Stimulated Growth of Capillary Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Endothelial receptor tyrosine kinases involved in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiopoietin-1 induces sprouting angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The Id proteins and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Identification of a Ca2(+)-dependent cell-cell adhesion molecule in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The role of integrins in the maintenance of endothelial monolayer integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Thalidomide: emerging role in cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiogenesis modulation in cancer research: novel clinical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Effect of p53 status on tumor response to antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Combined effects of angiostatin and ionizing radiation in antitumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Activity of thalidomide in AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

Extracellular Matrix-derived Peptide Binds to αvβ3Integrin and Inhibits Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.4.527

21 January 2018

Identifiers

DOI

10.1517/14728222.7.4.527

1 reference

7 August 2017

1 reference